Byrne Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.26K Buy
+80
New +$5.46K ﹤0.01% 478
2025
Q3
Sell
-190
Closed -$9.88K 579
2025
Q2
$9.88K Hold
190
0.01% 399
2025
Q1
$12.1K Buy
+190
New +$11K 0.01% 395

Other funds holding HALO

Byrne Asset Management's HALO Position: Q2 2026 in Review

Byrne Asset Management opened a new position in Halozyme (HALO) in Q2 2026: 80 shares worth $6.26K. The stake represents ﹤0.01% of the portfolio and ranks #478 among its holdings. This is a return to the name: Byrne Asset Management previously reported a position in HALO as recently as Q2 2025.

Byrne Asset Management first reported a position in HALO in Q1 2025 and has held it in 3 quarters since. The position peaked at $12.1K in Q1 2025. 127 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Byrne Asset Management held 80 shares of Halozyme worth $6.26K as of Q2 2026.
  • Halozyme was a new Byrne Asset Management position in Q2 2026.
  • Halozyme made up ﹤0.01% of Byrne Asset Management's portfolio in Q2 2026, its #478 holding.
  • Byrne Asset Management first reported a position in Halozyme in Q1 2025 and has held it in 3 quarters since.
  • Byrne Asset Management's Halozyme position peaked at $12.1K in Q1 2025.
  • 127 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.